(19)
(11) EP 1 144 448 A2

(12)

(43) Date of publication:
17.10.2001 Bulletin 2001/42

(21) Application number: 00902369.8

(22) Date of filing: 06.01.2000
(51) International Patent Classification (IPC)7C07K 14/415, C12N 15/63, C07K 16/18, C12N 15/11, G01N 33/53
(86) International application number:
PCT/US0000/459
(87) International publication number:
WO 0040/607 (13.07.2000 Gazette 2000/28)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.01.1999 US 227278

(71) Applicant: CHIRON CORPORATION
Emeryville,California 94608 (US)

(72) Inventor:
  • DUHL, David
    Oakland, CA 94611 (US)

(74) Representative: Irvine, Jonquil Claire 
J.A. KEMP & CO.14 South SquareGray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

 
Remarks:
WIPO A3 publication data is not currently available.
 


(54) TIAM2 (T-CELL LYMPHOMA INVASION AND METASTASIS 2) NUCLEOTIDE EXCHANGE FACTOR